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ABSTRACT 
 
Candida albicans is an opportunistic fungal pathogen that has the capability to switch 
from commensal to pathogen in immunocompromised individuals. Recognition of pathogens, 
like C. albicans, during infection is poorly characterized primarily due to the difficulties in 
visualizing the host/pathogen interaction without killing the host. Transparent animal hosts, such 
as Danio rerio (zebrafish), enable imaging of pathogen recognition while maintaining host 
viability. For pathogen recognition, zebrafish likely use immune receptors similar to mammalian 
receptors including C-type lectin receptors. Human C-type lectin receptors have already been 
shown to be crucial in recognition of fungal pathogens like C. albicans, and our goal is to 
identify and characterize cognate receptors crucial for fungal recognition in zebrafish. Here, I 
show how I purified fusion proteins of recently identified receptors and began characterizing the 
binding of these receptors to Candida albicans. Determining the specificity of these receptors 
may enhance our understanding of fungal recognition in the zebrafish host and the evolution of 
vertebrate immune receptor specificity. In addition, receptors that bind to C. albicans could be 
used as a diagnostic for C. albicans infection in patients. 
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INTRODUCTION 
i.   Overview 
 Opportunistic pathogens have become a major concern in the realm of infectious disease. 
While asymptomatic in healthy individuals, these pathogens have the ability to cause significant 
infections in patients undergoing immune-suppressing procedures. Candida albicans is an 
opportunistic fungal pathogen that causes diseases ranging from oral thrush to candidemia in 
immunocompromised individuals. Recognition of pathogens, like C. albicans, during infection is 
poorly characterized primarily due to the difficulties in visualizing the host/pathogen interaction 
without killing the host. Transparent animal hosts, such as Danio rerio (zebrafish), are necessary 
to accomplish the task of imaging pathogen recognition while maintaining host viability. In 
addition to being transparent, zebrafish share genetic relatedness to humans and are easy to 
manipulate. For pathogen recognition, zebrafish likely use immune receptors similar to 
mammalian receptors: Toll-like receptors, Nod-like receptors, and C-type lectin receptors. 
Human C-type lectin receptors have already been shown to be crucial in recognition of fungal 
pathogens like C. albicans. The long-term goal of this research is to identify and characterize 
potential zebrafish receptors that mediate C. albicans recognition. In addition, we hope these 
studies will provide insight into the evolutionary relationship between zebrafish and mammalian 
immune systems.  
 
ii.   Candida albicans - an opportunistic pathogen 
 Nosocomial candidemia (Candida in the bloodstream) is an ongoing public health 
concern. In 2000, C. albicans accounted for 5 – 10% of all nosocomial bloodstream infections in 
acute care hospitals, with a 25% mortality rate (17). The medical costs associated with hospital 
acquired candidemia were reported upwards of $34,000 per patient (10,17). Other complications 
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from infection with Candida species include oral, gastrointestinal, and vaginal thrush. Ninety 
percent of acquired immunodeficiency syndrome patients (AIDS) patients suffer from oral 
candidiasis, which is the most common oral manifestation of HIV infection (18). Candida 
albicans is also the most common species associated with candidiasis and candidemia (20). C. 
albicans has the ability to switch from commensalistic to pathogenic in immunocompromised 
hosts (patients with AIDS, undergoing chemotherapy, or receiving immunosuppressant drugs for 
organ transplants). Determining the mechanisms of this molecular switch has been an ongoing, 
complex process. 
C. albicans possesses morphological plasticity, meaning it can exist in yeast, 
pseudohyphael, and hyphal forms. Many studies have shown that the hyphal form is responsible 
for invasive candidiasis. In murine models, prevention of the filamentous form inhibits C. 
albicans growth and hinders dissemination (11). In addition, yeast cells that are engulfed by 
macrophages switch to hyphal form to escape the macrophage (13). Alternatively, the yeast form 
of C. albicans is responsible for the pathogen’s ability to disseminate and cause secondary 
infections (9). Candida’s ability to both invade the mucosal and epithelial barriers and to 
disseminate and cause systemic infections makes it very difficult to treat. 
 
iii.  Innate immunity and pattern recognition receptors (PRRs) 
Introduction of foreign invaders into the human body leads to stimulation of the innate 
immune response via pattern recognition receptors (PRRs). These PRRs are displayed on the 
surface of specific innate immune cells and bind to pathogen associated molecular patterns 
(PAMPs). This PAMP-PRR interaction initiates signaling cascades that elicit a nonspecific 
immune response to the invader. PAMPs can be many different things, including carbohydrates, 
nucleic acid methylation patterns, lipopolysaccharides, and proteins. There is promiscuity with 
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PRRs, meaning many PRRs can recognize different PAMPs and many PAMPs stimulate more 
than one PRR. While the response generated is PAMP/PRR specific, it is not specific to the 
pathogen and thus does not confer long term immunity. 
 Pattern recognition receptors are classified based on the class of molecules they recognize 
and the type of receptor. These include Toll-like receptors (TLRs), NOD-like receptors (NLRs), 
and C-type lectin receptors (CLRs). C-type lectin receptors, which are highly conserved across 
the animal kingdom, are typically expressed on myeloid and mucosal epithelial cells (22). All C-
type lectin receptors contain at least one carbohydrate recognition domain (CRD) and can exist 
as either a soluble or transmembrane receptor. While there are currently seventeen identified C-
type lectin groups, only those of Groups II, III, IV, V, and VI have shown important roles in 
innate immunity. Dectin-I (Group V) and Dectin-II (Group II) are primarily responsible for 
recognition of Candida albicans in humans. 
The cell wall of C. albicans serves a greater role than just protection against osmotic 
offense, and has been shown to be a “dynamic organelle” (7). Approximately 80–90% of the cell 
wall are carbohydrates, including β(1-3)-glucan and β(1-6)-glucans, N-acetyl-D-glucosamine, 
and mannan. Dectin-I recognizes and binds to β(1-3)-glucans and elicits a proinflammatory 
response at the site of infection. By masking β-glucan with mannan, C. albicans is able to evade 
immune recognition by Dectin-1. However, Dectin-II, Mincle, and DCSF recognize and bind 
mannan and also elicit a proinflammatory response. Due to its dynamic nature and contribution 
to virulence, it is important to determine which receptors bind which components of C. albicans 
cell wall in the zebrafish model.  
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iv.  Danio rerio as a research tool to study fungal infection 
 One of the major difficulties with studying host-pathogen interaction in vivo is the 
necessity for a transparent host. For this reason, the zebrafish model is of extreme benefit as 
opposed to using the murine model. Using the zebrafish larval model allows for real-time 
imaging of C. albicans infection, both invasive and disseminated. The other commonly known 
benefits of using zebrafish are their genetic relatedness to humans, large brood size, short 
generation time, and ease of care and genetic manipulation. Zebrafish are also one of the smallest 
animal models with both an innate and adaptive immune system (15). The greatest advantage in 
studying the innate immune-fungal interaction is that zebrafish only have an innate immune 
system until they reach adulthood (4–6 weeks post fertilization). Since C. albicans recognition in 
humans is a primarily innate response, this makes the zebrafish larval model as an ideal tool for 
studying Candida infection.  
 
v. Current and previous research 
 It has yet to be determined which innate receptors of zebrafish recognize C. albicans. 
While the downstream signaling of innate receptors is highly conserved across the animal 
kingdom, the extracellular domains of the receptors have evolved rapidly over time. The 
evolution of the carbohydrate recognition domain (extracellular portion) of C-type lectin 
receptors has been driven by pathogenic evolutionary pressures (3). Only the membrane-
embedded portion of C-type lectin receptors have been conserved across animal models 
including Saccharomyces cerevisiae, Caenorhabditis elegans, and Drosophila melanogaster (8). 
The Group V C-type lectin receptors have not been found in teleost fish, suggesting there is not a 
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direct Dectin-1 homolog in these fish. While there are Group II C-type lectin receptors in 
zebrafish, there has yet to be a Dectin-2 homolog discovered.  
It has been documented numerous times that C. albicans recognition in zebrafish is 
primarily an innate response.  NADPH-oxidase dependent phagocyte recruitment during early 
infection is a critical requirement for pathogen clearance (4). Neutrophil recruitment during early 
infection is needed to prevent filamentous growth which causes invasive candidiasis (16).  For 
this reason, the purpose of this study has been to identify innate receptor(s) that are responsible 
for recognition in zebrafish to further the understanding of C. abicans infection in this animal 
model. 
 The beginnings of this project were conducted by Erin Carter of the Wheeler lab. Using 
sequence homology, several potential fungal recognition receptors were identified (Fig. 2). Of 
these, seven receptors were cloned for further studies. The following is the name of each of the 
receptors and the recognition done by the human ortholog. Dendritic cell-specific intercellular 
adhesion molecule-3 grabbing non-integrin like F (DCSIGN-F or DCSF) recognizes high-
mannose-containing glycoproteins (14). Cluster of Differentiation 209 (CD209) binds 
carbohydrate ligands on various microbial surfaces including C. albicans (5). There is no human 
homolog, of dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin like 
G (DC-SIGN-like-G or DSLG) but it is related to human DCSIGN, also known as CD209 (2). 
Zebrafish killer cell lectin 1B (KCL) shares homology with human CD209 (6). Immune-related 
lectin-like receptor 1 (ILLR1) possesses an activation motif typically seen in Group V natural 
killer T-cell receptors (19). Asialoglycoprotein receptor 2 (ASGPR2) binds to galactaose residues 
located on microbial surfaces (12). Salmon C type Lectin Receptor A (SCLRA) shares the most 
homology to human Dectin-1 (6).  
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 All seven identified receptors were cloned into plasmids with a secretion tag (Fig. 3). 
This was done by fusing the carbohydrate recognition domain (CRD) to the constant portion of 
human Fc. The construct contained a pSecTag2 secretion tag which ensured that the protein 
would be secreted by cells expressing the plasmid. In addition, the receptors were labeled with 
GFP for fluorescence detection. Following creation of these soluble constructs, the plasmids 
were transfected into the HEK293T cell culture line. Secreted protein was collected, purified to 
contain only the receptor, and concentrated. Prior to the research discussed in this thesis, five of 
the receptors had been purified in this manner. 
 The research discussed in this thesis begins with purification of the remaining two 
receptors, ILLR1 and ASGPR2. Following this, characterization using luminescence binding 
assays were conducted on four previously purified receptors. These studies were done to build 
upon the fluorescence microscopy experiments conducted by Riju Shresta, who did her capstone 
in the Wheeler Lab. The goal of this thesis research has been to determine the binding affinities 
of the zebrafish receptors to C. albicans using luminescence high-throughput binding assays. 
This information will contribute to a broader understanding of innate immune recognition of C. 
albicans in the zebrafish model. In addition, this will allow for in vivo studies to be conducted to 
corroborate the results found.  
 
MATERIALS AND METHODS 
i. Cell Culture Maintenance 
 A Steril Gard II laminar flow hood was used to prevent contamination while conducting 
the cell culture procedures. HEK293T (Human Embryonic Kidney) cell line was used and grown 
in T75 flasks that were placed in a 37ºC incubator for overnight storage. When the HEK293T 
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cells reached approximately 90% confluence, as determined by viewing under an inverted 
dissecting microscope, the cells were split to double the original number of flasks. Minimum 
essential medium supplemented with 10% filter-sterilized FBS, 1µM sodium pyruvate, and 1% 
gentamyacin (to prevent contamination) was used for the cells. HEK293T cells are adherent 
cells, so the media (~20mLs) was pulled off without disturbing the cells. 4 mL of 0.5% trypsin-
EDTA (Gibco by Life Technologies) was added to the flask to un-adhere the cells. The flask 
containing trypsin was incubated for 5 minutes at 37ºC. Following this incubation period, 16 mL 
of fresh media was added to the flask. The fresh media, now containing the HEK293T cells, was 
pulled off and transferred to a 50 mL falcon tube. This tube was centrifuged at 1,000rpm for 3 
minutes using a Sorvall ST16 centrifuge (Thermo Fisher Scientific). The pelleted cells were then 
resuspended in fresh culture media. Using 2 new T75 flasks, 2mL of the resuspended cells were 
placed in 18 mL of fresh media for each of the flasks. These flasks were then incubated at 37ºC 
until reaching confluence, at the process was repeated. 
 
 
ii.  Polyplus Transfection of HEK293T cells using jetPRIME 
 HEK293T cells were transfected using a Polyplus jetPRIME transfection kit. HEK293T 
cells were taken out of liquid nitrogen storage and grown in a T75 flask. The cells were split into 
two T75 flasks following the procedure for Cell Culture Maintenance. This was done to ensure 
the freshly thawed cells would grow properly before conducting a transfection. Media was 
removed from the flasks, and the HEK293T cells were trypsinized. Following the trypsinization 
incubation, 16 mL of fresh media was added and the media, now containing the cells, was 
transferred to a 50 mL falcon tube. Following centrifugation at 1,000 rpm for 3 minutes, the 
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pelleted cells were resuspended in 4 mL of fresh media and transferred to a new T75 flask. An 
additional 6 mL of fresh media was added, to bring the total volume to 10 mL. 
 In a microcentrifuge tube, 500 µL of jetPRIME buffer, 10 µg of receptor DNA (Table 1), 
and 30 µL of jetPRIME reagent were combined. The microcentrifuge tube was then vortexed for 
10 seconds and short spun in a centrifuge. This reaction was allowed to incubate at room 
temperature for 10 minutes. 200 µL of this transfection mixture was added to the T75 flask 
containing HEK293T cells. The flask was incubated at 37ºC. Since the soluble receptor 
constructs induce Zeocin resistance, Zeocin was added the day following transfection to select 
only transfected cells. Transfections were carried out for approxiametly 4-5 weeks to ensure a 
stable line had been created. 
 
Name of 
Receptor 
Concentration 
(ng/µL) 
Amount Added 
(µL) 
ILLR1 775.8 12.9 
ASGPR2 187.7 53.6 
Table 1. Concentration of Receptors 
 
iii.  Bioreactor Collection of Solubilized Protein 
 Since the receptors contain a SecTag that allows them to be secreted from the HEK293T 
cells, a CellLINE bioreactor was used to collect large amounts of protein. Using a 
hemocytometer, cell count was determined of the transfected cells. The desired concentration 
was 2.5 x 106 cells/mL to be placed into the bioreactor. This volume of cells was added to 10 mL 
of “special media” which contained 10% low IgG FBS instead of 10% HI-FBS. This media 
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containing the transfected cells was placed into the inner compartment of the biorecactor. 100 
mL of regular media was placed into the outer compartment of the bioreactor along with 1 mL of 
Zeocin (to maintain selection). Every 7 days, the media was collected from the small 
compartment and spun down. The supernatant containing the soluble protein was kept and stored 
at -20ºC until the time came for protein purification. The bioreactor was maintained for 5-6 
weeks to ensure adequate protein collection. 
 
iv.  Receptor Protein Purification 
 Transfected HEK293T supernatants were thawed to room temperature prior to 
purification. Receptor purification was done using a Hitrap-Protein A column (GE Healthcare). 
Hitrap-Protein A column was also brought to room temperature prior to use (stored at 4ºC when 
not in use). The column was prepared using a 10 mL syringe loaded with 10 mL of binding 
buffer (1x PBS). The syringe was attached as recommended by the manufacturer with a luer lock 
adaptor that was also connected to the Protein A column. The flow through was collected in a 50 
mL waste Falcon tube. To prevent the introduction of an air bubble, the syringe was 
disconnected from the adaptor when ~0.5mL of binding buffer remained. Between each loading 
step, a drop of 1x PBS was added to the top of the column to prevent drying the column. After 
the column was prepped, a syringe loaded with 10.5 mL of receptor supernatant was applied to 
the column, stopping at 0.5 mL as before. The flow rate was kept at a constant 1-2 mL per 
minute. The column was then washed with 10 mL of binding buffer (1x PBS). Following this 
washing step, 5.5 mL of elution buffer (100mM glycine, 150mM NaCl, 0.05% NaN3, pH 2.8) 
was loaded into a syringe and 5 mL was pushed through the column. The flow through was 
collected in a clean 15 mL falcon tube containing 0.75 mL neutralizing buffer (1M Tris, pH 9). A 
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final washing step with 1x PBS was conducted before the column was placed in a 15 mL Falcon 
tube containing 1x PBS. 
 
 
 
v.  Dialysis of Purified Receptor Protein 
 The purified eluate was dialyzed against 1x PBS using a Slide-a-lyzer 20,000 MWCO 
cartridge (Thermo Scientific). A plastic beaker was filled with 1 liter of 1x PBS. The Slide-a-
lyzer cartridge was soaked in the beaker of 1x PBS for 3 minutes before being loaded with the 
purified eluate using a syringe and 18 gauge needle. After the sample was loaded, the syringe 
and needle was used to remove any air from the inside of the cartridge. The cartridge was 
attached to a floatation device and placed back in the beaker containing 1x PBS along with a stir 
bar. This beaker was placed on a stir plate at 4ºC. After one hour of dialysis, the 1 liter of PBS 
was replaced with a fresh liter of PBS. Dialysis was then allowed to continue overnight. The 
following day, the sample was removed using a syringe and 18 gauge needle and transferred into 
a 15 mL Falcon tube to be left on ice. 
 
vi.  Centrifugal concentration of dialyzed protein receptors 
The dialyzed receptor protein was concentrated using 4 Amicon Ultra 0.5 mL 3k 
membrane microconcentrators (Millipore). To each of the microconcentrators, 500 µL of 
receptor protein was added. The microconcentrators were centrifuged at 14,000xg for 30 minutes 
at 4ºC. The microconcentrators were hen inverted and transferred to new microcentrifuge tubes. 
These were spun at 1,000xg for 2 minutes. This process was repeated until the dialyzed protein 
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was at a volume of approximately 500 µL. After concentration, 1 volume of 90% glycerol was 
added to the samples (final concentration of 45% glycerol). To prevent protein degradation, a 
Pierce protease inhibitor mini tablet, EDTA-free (Thermo Scientific) was added at a final 
concentration of 1x. The samples was then stored at -20ºC. 
 
vii.  Bradford Assay to Determine Protein Concentration 
 A Bradford Assay was conducted to determine the concentration of the purified receptor 
protein. 10 2-fold serial dilutions were made of bovine serum albumin (BSA) by adding 25 µL of 
BSA to 25 µL of 45% glycerol + PBS (what the receptor samples are stored in). This dilution 
was made 10 times down to a concentration of 9.7 x 10-3 µg/µL. Using a 96-well plate, 10 µL of 
the BSA dilutions were added to respective wells in duplicates. 10 µL of 45% glycerol + 1x PBS 
was placed in two other wells for duplicate blanks. Two, two-fold dilutions (1:1 and 1:3 
dilutions) were made of the concentrated receptor proteins in 1x PBS. 10 µL aliquots of the 
undiluted receptor protein, the 1:1 dilution, and the 1:3 dilution were added in duplicate to the 
96-well plate. To each of the wells containing protein (BSA or receptor), and the blanks, 90 µL 
of Bradford solution was added using a multi-channel pipette. The 96-well plate was allowed to 
sit for 10 minutes at room temperature on a plate revolving apparatus. Absorbance readings were 
then taken at 595 nm using a plate reader. 
 A Bradford standard curve was created using the 10 BSA dilution readings, blank 
subtracted (BSA A595 – 1x PBS A595). A linear regression line was created using Excel, and the 
protein concentrations of the receptor samples were calculated from the linear equation. 
 
viii.   Validation of Protein Purification via SDS-PAGE and Western Blot 
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 A SDS PAGE was first conducted to separate the protein based on size. Samples were 
prepared by adding approximately 1µg of protein to SDS-PAGE preparation buffer (40% 
Glycerol, 240 mM Tris/HCl pH 6.8, 8% SDS, 0.04% bromophenol blue, 5% beta-
mercaptoethanol). The samples, including an aliquot of Kaleidoscope standard, were boiled for 5 
minutes before being centrifuged for 10 seconds. A TGX (tris-glycine) precast gel was added to 
the gel holder. 10µL of sample was loaded to each well: ASGPR2, ILLR1, Dectin-1 (positive 
control), and 2 wells of Kaleidoscope standard (Figure 1A). SDS-PAGE buffer was added to the 
gel compartment. The gel was run for ~50 minutes at 200V to allow for size separation. 
 After SDS-PAGE, the proteins were transferred to a nitrocellulose membrane and 
assayed using a Western Blot. The Ready Gel Blotting Sandwich was arranged as according to 
Bio-Rad’s instructions (Figure 1B). This sandwich was soaked in Towbin buffer (tris base and 
glycine), before being run at 25V for 20 hours. The following day, the nitrocellulose membrane 
now containing the protein, was washed in TBS for 5 minutes (200mM tris and 500 mM NaCl). 
To prevent any nonspecific binding, the membrane was blocked for 1 hour in blocking solution 
(40 mL TTBS with 2g of nonfat milk) at room temperature. Following blocking, antibody 
staining was conducted using 0.04ng/mL HRP-conjugated goat anti-human IgG (Jackson 
ImmunoResearch) for 30 minutes at room temperature. The membrane was then washed 4 times 
in TTBS, 5 minutes per wash, to remove any excess blocking solution or secondary antibody. 
Western Blotting Chemiluminescence Substrate was added before the membrane was imaged. 
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Figure 1. Western Blot was conducted to confirm protein purity. (A) Kaleidoscope 
standard used for protein size in SDS-PAGE. (B) Bio-Rad Western Blotting Sandwich 
arrangement. Image sources: Bio-Rad (A); ThermoFisher Scientific (B). 
ix.  High-Throughput Luminescence Staining 
 Wildtype-EGFP (WT-EGFP) and KAH3-EGFP C. albicans strains were streaked for 
isolation onto YPD plates (2% Bacto Peptone, 1% Bacto Yeast Extract, 2% Glucose, 2% Bacto 
Agar) and grown for 2 days at 37ºC. A single colony of WT-EGFP and a single colony of 
KAH3-EGFP were each inoculated into 3 mL of YPD. 1:100 inoculums were done of each by 
taking 200 µL of the original inoculum and adding it to 1.98 mL of YPD. The original inoculums 
and the 1:100 inoculums were incubated overnight at 30ºC in a roller drum. 
 The following day, 1 mL of each overnight inoculum was spun down for 30 seconds at 
21,000 xg. The cells were then washed three times with 1 mL of 1x PBS, before being 
resuspended in 1 mL of 1x PBS. To determine cell count, an OD50 reading was taken. The 
spectrophotometer was blanked used 1 mL of 1x PBS. Each sample was diluted 1:100 by adding 
10 µL of sample to 990 µL of 1x PBS. The volume of the sample to be added to 8 mL of RPMI 
was calculated using the following equation: 
 (x mL of 1:100)(OD50)(107)(100) = (8 mL RPMI)(desired cell concentration) 
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 Using a multichannel pipette, 160µL of C. albicans in RPMI was added to each of the 
wells in a 96-well cell binding plate. The plate was sealed and incubated at 37ºC for 3-4 hours to 
allow cell adherence. Following this incubation period, the cells were washed three times using 
100 µL of 1x PBS. Cells were blocked for 30 minutes at room temperature using 100 µL of 1x 
PBS + 2% BSA. Cells were washed three times with 1x PBS. Addition of 50 µL of receptor at a 
desired concentration was added to all wells except for those chosen to be no-receptor negative 
controls. Receptor binding occurred at room temperature for 1 hour. After receptor binding, cells 
were washed three times with 1x PBS. Addition of 50 µL of Biotin-SP-conjugated AffiniPure 
Donkey Anti-Human IgG FC (Jackson ImmunoResearch) took place for 20 minutes on ice. 
Following 2º antibody addition, cells were washed three times with 1x PBS. Streptavidin-HRP 
was added for 20 minutes on ice. Cells were washed three more times with 1x PBS. Using a plate 
reader, a GFP read was taken of the 96-well plate. A 1:1 dilution of Western Blot Substrate dark 
solution to bright solution was created. PBS was removed from the wells and 50 µL of this 
luminescence substrate was added. A luminescence read was then taken using the plate reader. 
 
RESULTS 
i.  Overview 
 Zebrafish have proven to be an extremely useful model for studying infection with the 
opportunistic fungal pathogen Candida albicans. While it has been demonstrated that candidiasis 
in zebrafish leads to a primarily innate immune response, the receptors involved in recognition 
have yet to be determined. This project has been focused on answering this question, with the 
goal of furthering understanding of candidiasis in this animal model. The work discussed in this 
thesis picks up with expression and purification of two potential zebrafish receptors to allow for 
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receptor purification. Following purification, screening for receptor binding to C. albicans was 
conducted using high-throughput luminescence binding assays. 
 
ii.  Expression of zebrafish receptors was achieved using Polyplus Transfection 
To identify potential targets for zebrafish pattern recognition receptors, we sought to test 
the ligand specificity of purified soluble versions of the receptors. Previous work led to the 
cloning of seven zebrafish Type II C-type lectin carbohydrate recognition domains (CRDs) in a 
mammalian expression vector. The carbohydrate recognition domains of two zebrafish receptors, 
ILLLR1 and ASGPR2, had been previously cloned into a mammalian expression vector and these 
could then be stably transfected into HEK293T cells. HEK293T (Homo sapiens Embryonic 
Kidney) cells are widely used for various cell culture applications. They have the benefits of 
being adherent, making passaging easy, and transfect very rapidly. The expression constructs 
used contained the CRD region of the desired receptor, a secretion tag, the constant portion of 
human IgG Fc, and a gene encoding for zeocin resistance (Fig. 3). The secretion tag allowed for 
receptor secretion from transfected HEK293T cells. By fusing the CRD to the constant portion of 
human IgG Fc, the same purification and secondary antibody for receptor screening could be 
used for all the receptors including the positive control. Lastly, zeocin resistance allowed for 
positive selection of transfected cells by eliminating nontransfected cells.  
Upon transfection, a stable cell line was created by positive selection with zeocin 
antibiotic. Positive selection initially led to decreased observed growth rate because the majority 
of cells were killed and HEK293T cells require growth factors from neighbors to grow normally. 
Thus, cells were allowed to grow for several weeks until they returned to normal growth rate, 
ensuring the cell line was stable. To make certain the cell line wasn’t just evolving from a subset 
	   16	  
of inherently zeocin resistant cells, a negative control was conducted at the same time with non-
transfected HEK293T cells being treated with the same amount of zeocin as transfected cells. 
Negative controls typically died within a few days after zeocin treatment had begun (Table 3-6). 
Two different transfection protocols were conducted to express the receptor constructs. 
Originally, two AMAXA nucleofections (Table 2) were conducted with the ILLR1 receptor 
construct. However, the cell populations never recovered from the nucleofections. Next, a 
jetPRIME Polyplus transfection protocol (Fig. 4) was tried with the ILLR1 receptor construct. 
The first attempt didn’t survive, but the second attempt was successful at creating a stable 
transfected cell line (Table 3). Some of the transfected cells were frozen down and these were 
maintained in a CELLine bioreactor (Fig. 5) for 6 weeks. The transfected cells were placed in a 
small compartment and media was placed in a large compartment of the bioreactor. A low 
molecular weight filter allowed for passage of nutrients and waste but excluded secreted proteins 
from leaving the small compartment. This allowed for protein concentration and samples were 
taken out every week for purification. Due to the success of the jetPRIME Polyplus transfection, 
this protocol was used for expression of the ASGPR2 receptor construct (Table 4-6). A stable line 
was created and maintained for several weeks before being placed in a bioreactor for 7 weeks 
(Table 6). 
 
iii. Purification of zebrafish receptors was achieved using HiTrap Protein A Columns 
Since HEK293T cells secrete proteins other than the receptors, and the growth media 
contains some bovine proteins, protein purifications were conducted on samples taken from the 
bioreactor. The secreted protein was applied to a HiTrap Protein A column. Protein A is a 
surface protein found on Staphylococcus aureus that binds to the constant portion of human Fc 
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(fused to the receptor CRD of the expression constructs). The HiTrap columns were prepared by 
washing with phosphate buffer solution (PBS). The supernatants of the bioreactor samples were 
applied to the column to allow the lysate to bind to the Protein A. Any unbound protein was 
washed off using PBS before an elution buffer was applied. This buffer is highly basic which 
leads to a conformational change and release of the lysate. The purified protein was dialyzed 
against PBS to remove the elution buffer and was then concentrated. Bradford assays suggest 
there was enough protein produced and purified for subsequent analysis (Table 7).  
 
 
 
iv. Western Blot was performed to determine purification quality 
 An SDS-PAGE was performed to separate purified protein based on molecular weight. 
This was followed by a Western Blot to transfer purified protein onto a Western Blot membrane. 
Immunodetection was done on the Western Blot membrane to determine if the purified protein 
was the desired receptor. The expected molecular weights of Dectin-1 is 49.4 kDa, ILLR1 is 
45.1, ASGPR2 is 47.6 kDa, and IgG Fc alone is 27.3 kDa. However, the immunodetection results 
(Fig. 6) show lower molecular weights for ILLR1 and ASGPR2. The bands are around 27 kDa, 
which is the molecular weight of Fc alone. This result suggests that only the Fc portion purified 
of the ILLR1 and ASGPR2 receptor constructs. A proteolytic cleavage event likely occurred, 
separating the Fc and CRD portions. 
 
v. Development of a high-throughput screening assay for measuring binding of CRD-Fc fusions 
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 Previous screenings done with the purified zebrafish receptors utilized fluorescence 
microscopy. While this technique is useful for visualization, the goal of this part of the project 
was to obtain large amounts of quantifiable data. Fluorescence microscopy has very low 
throughput, thus in order to determine binding affinities for each of these receptors a higher 
throughput protocol needed to be used. Previous research in the Wheeler Lab using 96-well 
CellBIND plates for screening antifungal compounds against C. albicans proved to be an 
efficient screening method with a large output. CellBIND plates are adherent, which allow the C. 
albicans to bind to the plate with minimal disruption from continued pipetting.  Based on these 
previous studies, a protocol using CellBIND plates was developed to screen the binding affinities 
of several receptors at once.  
In order to determine the optimal conditions for these screens, numerous optimization 
experiments were conducted with the positive control CRD-Fc fusion, Dectin-1-CRD-Fc. Two 
GFP labelled C. albicans strains were used: wildtype and KAH3. KAH3 is a strain that has a 
mutated cell wall with decreased mannan allowing β-glucan to be exposed. By using KAH3 and 
wildtype, the type of carbohydrate the zebrafish receptor binds to can be inferred (mannan versus 
β-glucan). KAH3 also allows for detection of other layers of the cell wall besides the top most 
mannan layer in wild type C. albicans. Dectin-1 is a β-glucan receptor, thus higher levels of 
binding to the KAH3 strain should be seen, creating an additional parameter to determine the 
accuracy of the screen. For all the high-throughput experiments discussed in this thesis, C. 
albicans was incubated in the CellBIND plates for 3-4 hours. This length of time was previously 
determined to be sufficient for cell adherence to the wells. The optical density at 600 nm 
absorbance was used to achieve the desired C. albicans concentration. 
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    a. HRP-conjugated α-human IgG leads to excess background signal 
Based on previous studies and for simplification, an Horseradish Peroxidase (HRP) 
conjugated α-human IgG secondary antibody (Fig. 7) was first used to detect C. albicans-bound 
receptors. Following an incubation with bovine serum albumin (BSA) to prevent non-specific 
binding, Dectin-1 and HRP-conjugated α-human IgG were added to the wells. This secondary 
antibody was found to have limitations, however. A high enough concentration of secondary 
antibody to bind to the Dectin-1 provided too high of a background luminescence. The data was 
analyzed by taking the luminescence read (corresponds to amount of secondary antibody-
receptor bound to the C. albicans) and dividing this by the GFP read (amount of C. albicans in 
the respective well). A difference in LUM/GFP could be seen as the secondary antibody 
concentration increased, but no significant difference could be seen with increasing C. albicans 
concentration (Fig. 8). For this reason, an alternate secondary antibody was needed to eliminate 
background luminescence that significantly inhibited screening purposes. 
 
b. Biotinylated α-human IgG allows for more specific luminescence detection of Dectin-1 
 In order to decrease background luminescence from a high HRP concentration, a 
biotinylated  α-human IgG secondary antibody was used. In addition, this antibody allows for 
bivalent interactions with receptors to increase avidity of the antibody-receptor complex. 
Streptavidin has an extremely high affinity for biotin, and was thus used to bind to the 
biotinylated  α-human IgG (Fig. 9). A higher secondary antibody concentration could then be 
used when followed by binding with a lower concentration of Streptavidin conjugated with HRP. 
The optimal concentration of biotinylated  α-human IgG and streptavidin was determined based 
on which concentration showed a higher luminescence of Dectin-1 with KAH3 as opposed to 
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wild type. Initially, very high dilutions were made (1:100 – 1:500 biotinylated  α-human IgG and 
1:500 – 1:1,000 streptavidin-HRP), however these were not concentrated enough for detection. 
Upon further experimentation, the optimal concentration of biotinylated  α-human IgG was 
determined to be a 1:20 dilution of the secondary antibody (Fig. 10A). The optimal concentration 
of streptavidin-HRP was determined to be a 1:100 dilution (Fig. 10B). These concentrations 
were used for the remainder of the high-throughput luminescence binding assays discussed in 
this thesis. 
 
vi.  High-throughput luminescence screening suggests candidate receptors for zebrafish C. 
albicans recognition 
 After determining the optimal protocol for the high throughput luminescence screen, the 
four candidate zebrafish receptors were tested (KCL, DCSF, CD209 and DSLG). DCSF did not 
appear to recognize either wild type or KAH3 C. albicans (Fig. 11A). KCL showed minimal 
recognition of the KAH3 strain. CD209 showed similar recognition to both wild type and KAH3 
strains. DSLG showed significant recognition of the wild type strain and minimal recognition of 
the KAH3 strain (Fig 11A). None of the zebrafish receptors reached the level of Dectin-1 
recognition in either the wild type (Fig. 11B) or KAH3 (Fig. 11C) strains of C. albicans. 
 
DISCUSSION 
i. Overview 
 Recognition of Candida albicans leads to a primarily innate immune response in a human 
host. In order to study this recognition, the zebrafish larval model is used because zebrafish 
possess only an innate immune system until adulthood. The receptors that recognize C. albicans 
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in zebrafish have yet to be determined, although this information is necessary to fully understand 
the infection within this model. In addition, this information could provide insight into the 
evolution of vertebrate innate immunology and the characteristics of the zebrafish innate immune 
system as a model for studying mammalian innate immunity. In continuation of a previous 
project aimed at identifying these cognate receptors, I attempted to purify two zebrafish C-type 
lectin receptors. I also worked to develop a high throughput method for determining binding 
affinities of these receptors to C. albicans that can be easily adapted to detecting binding 
affinities for other microbes. These early studies suggest that DSLG and CD209 have the 
capacity to recognize C. albicans. 
 
ii.  Transfection of HEK293T cells can be used to express zebrafish receptors 
 HEK293T cells are widely used for protein production, have a high efficiency for various 
types of transfection, and reproduce easily and rapidly (21). This cell line was ideal for our 
purposes of expressing receptor constructs in high volumes. While two different transfection 
protocols were attempted, Polyplus jetPRIME transfection reagent was the most efficient 
transfection protocol. Another benefit of the HEK293T cell line for our purposes is that the cells 
are adherent, and thus were very easy to passage. This especially was useful when the transfected 
cells were placed into a bioreactor, and allowed us to routinely remove the secreted protein 
without disturbing the living cells. Based on these results, the Polyplus jetPRIME transfection 
protocol and CELLine bioreactors can likely be used for future expression and concentration of 
other zebrafish proteins. 
 
iii.  Immunodetection reveals the receptor constructs were not fully purified 
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 Based on the expected molecular weights of ILLR1 and ASGPR2, it does not appear that 
the receptor constructs were purified fully. The transfection protocol was used previously by 
another student and led to the purification of two of the other receptor constructs (CD209 and 
DSLG), and thus it is unlikely that the transfection was unsuccessful. In addition, looking at the 
time it took the negative control to die (only a few days), it is highly unlikely that the cells 
evolved from a subset of inherently zeocin resistant cells. The HiTrap purification, dialysis, and 
concentration protocols were identical to those used for purification of all of the other receptor 
constructs. It is possible that a protease was introduced, and led to the degradation of part of the 
protein. However, the fact that all three proteins are at approximately the same weight even 
though the purifications were done at very different times suggests this is unlikely as well.  
It appears that protein was purified that contains the human IgG Fc region, but it isn’t 
possible to determine whether there was something else present before the purification. The 
sequence of the expression constructs will have to be double-checked to ensure that there wasn’t 
an issue with the constructs. After that, the only other possibility would be that proteolytic 
cleavage occurred at some point leading to the separation of the CRD and Fc regions of the 
protein. The secondary antibody used for the western blot, goat α-human IgG-HRP, binds to the 
Fc portion. Any other protein present will not be detected by immunodetection, and thus another 
type of protein quantification test would have to be used (i.e. coomassie blue). 
 
iv.  High-throughput luminescence assays can be used to measure binding of CRD-Fc fusions 
 Developing a high-throughput luminescence assay protocol allowed for rapid detection of 
receptor binding interactions with C. albicans. This type of screen is necessary to obtain large 
amounts of quantifiable data, which can’t be done using fluorescence microscopy and also 
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eliminates user bias. Using Dectin-1, a known receptor for C. albicans in humans, the optimal 
conditions for the assay could be determined. Originally, goat α-human IgG-HRP secondary 
antibody was used because it was the same one used in the Western Blot. However, to reach a 
high enough concentration of secondary antibody for detectable interaction with the bound 
receptors, the HRP background signal was too high and interfered with interpretation of results. 
 Although using a biotinylated secondary antibody and streptavidin conjugated with HRP 
made a more complex interaction, it allowed for an increased secondary antibody concentration 
without increasing the HRP concentration. This decreased the background signal and helped with 
interpretation of results. Using both the wild type and KAH3 strains of C. albicans allowed us to 
use Dectin-1-Fc as a positive control. KAH3 has a mutated cell wall with the outer mannan layer 
removed and the inner layers of the cell wall (including β-glucan) exposed. Knowing that 
Dectin-1 is a receptor for β-glucan, the optimal conditions could be determined by which 
concentrations led to the biggest increase in luminescence of Dectin-1 bound to KAH3 as 
opposed to wild type. 
 Two of the purified zebrafish receptors showed apparent recognition of C. albicans using 
the optimized high-throughput luminescence assay. Luminescence was seen in both the wild type 
and KAH3 strain with CD209. DSLG only appears to recognize wild type C. albicans. While 
neither luminescence signal was as strong as Dectin-1, these results do suggest that these 
receptors are worth further characterization. 
 
v. CD209 in humans recognizes various microbes including C. albicans 
Both of the zebrafish receptors that showed binding, CD209 and DSLG (DC-SIGN-like-
G) are related to CD209 in humans, which is also known as DCSIGN. The human homolog of 
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CD209 has been shown to recognize various microbial ligands of bacteria, viruses, and parasites. 
Zebrafish Human CD209 recognizes several Candida species, although the ligand that CD209 
binds has yet to be determined (5). In a study to determine the extent to which pathogens have 
exerted selective pressure on CD209 in humans, it was found that CD209 has undergone a strong 
selective constraint (Barreiro, 2005). Thus, it is likely that recognition of pathogens, including C. 
albicans, by zebrafish CD209 and DSLG will be similar to that of CD209 in humans. 
 
vi. Current and future research 
 In order to confirm the results seen with the first luminescence assays, these experiments 
are being repeated to create a larger sample size. Based on sequence homology, it is highly likely 
that CD209 and DSLG will recognize C. albicans, but there isn’t enough data to confirm this at 
this point.  A set of experiments that will be conducted to help form a hypothesis would be to 
introduce excess ligand into the assay. For example, by adding excess β-glucan to the wild type 
CD209 assay, if there is decreased signaling this would suggest β-glucan could be the ligand 
CD209 binds to. 
 Following quantification using the conditions discussed in this thesis and excess ligand 
assays, visualization of this interaction will need to be recorded. Fluorescence microscopy on its 
own isn’t sufficient for determining binding affinities, but it can certainly be used to collaborate 
quantified data. In addition, microscopy will be the most likely method to observe the binding 
interaction in vivo. Taking this to the zebrafish model will be the final step in characterization of 
the role of these receptors in C. albicans recognition. Thus having record of what this interaction 
looks like in vitro will make in vivo observations easier. Morpholinos are a very common and 
easy way to knockdown genes in zebrafish and could be used to knockdown the genes encoding 
	   25	  
for CD209 or DSLG. Comparing cytokine expression of control and knockdown zebrafish would 
demonstrate the downstream signaling effects of recognition by the receptors. 
 It is highly unlikely that all of the purified receptors recognize fungal pathogens. 
Fortunately, adapting the high-throughput luminescence assay to detection of other microbes 
would be relatively simple. As long as the microbe being tested is adherent, the assay will remain 
the same. Determining the specificity of these receptors for various microbes will provide 
important information for understanding zebrafish innate immunity. Comparing sequence 
homology of these receptors to human innate immune receptors and the results observed from 
the binding assays will give insight into how vertebrate innate immunity has evolved from teolest 
fish to mammals. 
 
 
 
vii. Conclusion  
 Candida albicans is the third leading cause of nosocomial infections in hospitalized 
patients in the United States. This opportunistic pathogen can cause various infections, including 
lethal invasive candidiasis in immunocompromised patients. In order to develop treatments for 
C. albicans infection, the role of specific immune cells in recognition needs to be characterized. 
The larval zebrafish model is ideal for studying C. albicans infection, because they only possess 
an innate immune system. However, in order to understand how C. albicans is recognized in this 
model, the receptors involved need to be elucidated. The goal of this research project has been to 
determine which zebrafish C-type lectin receptors bind to C. albicans. This project also has two 
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broader implications: understanding how vertebrate innate immunology has evolved from teolest 
fish to humans and assessing the benefit of using zebrafish for fungal immunology research. 
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TABLES 
 
 Experiment Started 
 Experiment 
terminated 
 Zeocin added 
 Negative control 
died 
N.D. Not determined 
Surface 
Area 
Container 
2.0 cm2 1 24-well plate well 
3.7 cm2 1 12 well plate well 
9.61 cm2 1 6 well plate well 
75 cm2 T75 flask 
Key for Table 2 (below) 
Day AMAXA Nucleofection 
ILLR1 Attempt 1 
AMAXA Nucleofection 
ILLR1 Attempt 2 
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 Cell Container/ 
Surface Area 
Confluence Cell Container/ 
Surface Area 
Confluence 
-2 1 75cm2 flask 90% 1 75cm2 flask 90% 
-1 2 75cm2flasks Split 2 75cm2 flasks Split 
0 3 9.61 cm2 wells N.A. 3 9.61 cm2 wells N.A. 
1 3 9.61 cm2 wells 40% 3 9.61 cm2 wells N.D. 
2 3 9.61 cm2 wells 60% 3 9.61 cm2 wells 40% 
3 3 9.61 cm2 wells 90% 3 9.61 cm2 wells N.D. 
4 6 9.61 cm2 wells Split 6 9.61 cm2 wells Split 
5 6 9.61 cm2 wells 30% 6 9.61 cm2 wells 50% 
6 6 9.61 cm2 wells 40% 10 9.61cm2 
wells 
Split 
7 6 2.0 cm2 wells Condensed 10 9.61cm2 
wells 
70% 
8 6 2.0 cm2 wells N.D. 1 75cm2 flask Combined 
9 6 2.0 cm2 wells 40% 6 9.61 cm2 
wells 
Condensed 
10 6 2.0 cm2 wells 40% 12 3.7 cm2 
wells 
Condensed 
11 6 2.0 cm2 wells 20% 12 3.7 cm2 
wells 
30% 
12 6 2.0 cm2 wells Cells died 12 3.7 cm2 
wells 
N.D. 
13   12 3.7 cm2 
wells 
Cells died 
Table 2. AMAXA Nucleofection was unsuccessful at expressing the ILLR1 receptor 
construct in the HEK293T cell line. In an attempt to create a stable cell line expressing the 
ILLR1 receptor construct, two AMAXA Nucleofections were attempted. 
 
 Experiment started 
 Experiment 
terminated 
 Zeocin added 
 Negative control 
died 
 Bioreactor started 
 Cells frozen down 
 Thawed frozen 
cells 
N.D. Not determined 
Key for Tables 3-6 (below) 
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Day Polyplus Transfection 
ILLR1 Attempt 1 
Polyplus Transfection 
ILLR1 Attempt 2 
 Number of T-
75 Flasks 
Confluence Number of T-75 
Flasks 
Confluence 
-1 1 40% 1 40% 
0 1 80% 1 80% 
1 1 → 2 Split 1 → 2 Split 
2 2 40% 2 N.D. 
3 2 Cells died 2 70% 
4   2 → 4 Split 
5   4 40% 
6   4 N.D. 
7   4 → 8 80% 
8   8 → 10 Two were split 
9   10 40% 
10   10 → 5 Condensed 6 to 
1 
11   5 → 10 Split 
12   10 70% 
13   10 90% 
14   2 → 4 Two not frozen 
down were split 
15   4 N.D. 
16   4 → 8 Split 
17   8 40% 
18   8 70% 
19   8 → 16 Split 
20   16 50% 
21   16 90% 
22   4 Froze down all 
but 4 
23   4 →8 Split 
24   8 Bacterial 
Contamination 
25   1 Thawed cells 
from freezer 
26   1  50% 
27   1 → 2  Split 
28   2 60% 
29   2 → 4 Split 
30   4 Placed in 
Bioreactor 
Table 3. Polyplus Transfection was successful at expressing the ILLR1 receptor 
construct in the HEK293T cell line. The second attempt at using the Polyplus transfection 
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protocol was successful at creating a stable cell line expressing the ILLR1 receptor construct. The 
transfected cells were placed into a CellLINE bioreactor to concentrate the secreted protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Day Polyplus Transfection 
ASGPR2 Attempt 1 
Polyplus Transfection 
ASGPR2 Attempt 2 
 Number of T-75 
Flasks 
Confluence Number of T-75 
Flasks 
Confluence 
-1 1 40% 1 40% 
0 1 80% 1 80% 
1 1 → 2 Split 1 → 2 Split 
2 2 40% 2 N.D. 
3 2 70% 2 60% 
4 2 → 4 Split 2 → 4 Split 
5 4 30% 4 40% 
6 4 N.D. 4 30% 
7 4 40% 4 → 2 Condensed 
8 4 40% 2 30% 
	   32	  
9 4 → 1 Condensed 2 Cells Died 
10 1 30%   
11 1 20%   
12 1 Cells Died   
Table 4. Polyplus Transfection was initially unsuccessful at expressing the ASGPR2 
receptor construct in the HEK293T cell line. In the initial attempts to transfect HEK293T with 
the ASGPR2 receptor construct, the cells didn’t make it through the positive selection phase. 
 
 
 
 
 
 
 
 
 
 
 
Day Polyplus Transfection 
ASGPR2 Attempt 3 
Polyplus Transfection 
ASGPR2 Attempt 4 
 Number of T-
75 Flasks 
Confluence Number of T-75 
Flasks 
Confluence 
-1 1 40% 1 40% 
0 1 80% 1 80% 
1 1 → 2 Split 1 → 2 Split 
2 2 40% 2 40% 
3 2 N.D. 2 80% 
4 2 20% 2 → 4 Split 
5 2 Cells Died 4 40% 
6   4 N.D. 
7 Experiment Note: trypsin volume 
wasn’t high enough to remove cells 
4 → 8 80% 
8 8 N.D. 
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from flask 
9   3 → 2 Froze down 5 
flasks 
10   2 30% 
11   2 Bacterial 
contamination 
12   1 Thawed Vial 
from freezer 
13   1 Bacterial 
contamination 
14   1 Thawed another 
vial from freezer 
15   1 Bacterial 
Contamination 
16   Experiment Note: Killed experiment 
and threw out remaining vials in the 
freezer; likely contamination came before 
freezing  
17   
18   
Table 5. Bacterial contamination killed cells transfected with the ASGPR2 receptor 
construct. Introduction of a bacterial contaminant inhibited the generation of a stable ASGPR2 
transfected cell line. 
 
 
 
 
Day Polyplus Transfection 
ASGPR2 Attempt 5 
 Number of T-
75 Flasks 
Confluence 
-1 1 40% 
0 1 80% 
1 1 → 2 Split 
2 2 40% 
3 2 → 4 Split 
4 4 50% 
5 4 → 8 Split 
6 8 N.D. 
7 8 50% 
8 8 70% 
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9 8 → 16 Split 
10 16 60% 
11 1 Froze down 15 
flasks 
12 1 N.D. 
13 1 → 2 Split 
14 2 50% 
15 2 → 4 Split 
16 4 60% 
17 4 Placed in 
Bioreactor 
Table 6. An ASGPR2 transfected HEK293T cell line was created using the Polyplus 
Transfection protocol. The final attempt at transfecting cells with the ASGPR2 receptor 
construct was successful. The transfected cells were placed into a CellLINE bioreactor to 
concentrate the secreted protein. 
 
 
 
 
 
 
 
Receptor Concentration 
ILLR1 Purification #1 0.459 mg/mL 
ILLR1 Purification #2 0.236 mg/mL 
ASGPR2 Purification #1 0.34 mg/mL 
Table 7. Bradford assays suggest there was enough purified protein for subsequent 
analysis. Bradford assays were conducted to determine the concentration of purified protein. 
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Figure 2. Association between various C-type lectin receptors. Image shows C-type lectin 
receptors belonging to group II (red), group V blue), NK-like receptors (green) in Danio rerio 
(Dre), Takifugu rubripes (Tru), Salmo salar (Ssa), Gallus gallus (Gga), Mus musculus (Mmu), 
and Homo sapiens (Hsa) aligned using Clustal W. The zebrafish receptors are highlighted in 
yellow. (Source: Erin Carter unpublished thesis, 2014) 
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Figure 3. Generation of plasmids containing zebrafish receptor carbohydrate recognition 
domain. Previous work done by Erin Carter of the Wheeler Lab led to the generation of seven 
zebrafish receptor constructs. The carbohydrate recognition domain (CRD) of each zebrafish 
receptor was fused with the constant portion of human IgG Fc, a gene coding for zeocin 
resistance, and a secretion tag. 
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Figure 4. Polyplus Transfection was used to express the ILLR1 and ASGPR2 receptor 
constructs in HEK293T cells. The transfection protocol was divided into two parts: initial 
transfection with jetPRIME reagents and the plasmid DNA containing the receptor constructs; 
positive selection for transformed cells using zeocin. Cells were placed in a bioreactor for 
collection of secreted protein. A no DNA transfection was used as a negative control.  
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Figure 5. CELLine bioreactor was used to concentrate transfected HEK293T secreted 
protein. The transfected HEK293T cells are placed in a small compartment in the bioreactor 
which is separated from the large compartment holding cell culture media by a low molecular 
weight filter. This filter allows for passage of nutrients and waste but inhibits secreted protein 
from exiting the small compartment. The secreted protein becomes concentrated and was 
removed every week for purification. Image source: The Lab Depot.  
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Figure 6. Immunodetection of ILLR1 and ASGPR2 receptor constructs suggests that the Fc 
portion was all that was purified.  An SDS-PAGE and Western Blot were conducted to 
determine if the protein expression and purification was successful. By looking at the 
corresponding molecular weights of the Kaleidoscope standard, it appears that only the Fc 
portion was purified of the ILLR1 and ASGPR2 receptor constructs. 
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Figure 7. HRP conjugated  α-human IgG secondary antibody was initially used for 
detection of Dectin-1-Fc in high-throughput luminescence screen. Initially, an HRP 
conjugated α-human IgG secondary antibody was used to detect levels of Dectin-1-Fc binding to 
wild type and KAH3 strains of C. albicans. BSA was used to prevent any nonspecific receptor 
binding. Addition of a western blotting substrate leads to a chemical reaction with the HRP that 
allows for chemiluminescence screening. 
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Figure 8. Increased secondary antibody concentration leads to apparent increase in 
detection of Dectin-1-Fc binding. By increasing the HRP conjugated a-human IgG 
concentration, there is an increase in level of luminescence per GFP. However, increasing the C. 
albicans concentration shows no significant difference in luminescence in either the wild type 
(A) or KAH3 (B) strains (the legend corresponds to cells/mL). This suggests that the increased 
secondary antibody concentration is providing excess background luminescence and false 
positive reads. 
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Figure 9. Biotin conjugated  α-human IgG secondary antibody was used for detection of 
Dectin-1-Fc in high-throughput luminescence screen. A biotin conjugated α-human IgG 
secondary antibody was used to detect levels of Dectin-1-Fc binding to wild type and KAH3 
strains of C. albicans. BSA was used to prevent any nonspecific receptor binding. Streptavidin 
conjugated with HRP (has a strong affinity for biotin) was used for chemiluminscence detection 
when treated with a western blotting substrate.  
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Figure 10. A 1:20 dilution of biotin conjugated with α-human IgG secondary antibody (A) 
and a 1:100 dilution of streptavidin conjugated with HRP (B) showed the greatest 
difference in luminescence between wild type and KAH3 strains of C. albicans. In order to 
determine the optimal concentrations of secondary antibody and streptavidin-HRP, the 
luminescence of Dectin-1 binding to wild type and KAH3 strains of C. albicans were compared. 
Dectin-1 is a receptor for β-glucan, which is more exposed in the KAH3 mutant strain than the 
wild type. Thus, the optimal concentrations were determined to be 1:20 of secondary antibody 
and 1:100 of strepatividin-HRP because these concentrations showed the greatest increase in 
luminescence in the KAH3 strain compared to the wild type strain. 
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Figure 11. High-throughput luminescence screen shows significant recognition of C. 
albicans by two candidate zebrafish receptors. (A) CD209 showed similar recognition of wild 
type and KAH3 strains of C. albicans. DSLG showed higher recognition of wild type strain than 
KAH3. KCL and DCSF didn’t appear to recognize C. albicans. (B) Of the zebrafish receptors, 
CD209 and DSLG showed the highest recognition of the wild type strain. (C) Of the zebrafish 
receptors, CD209 showed the highest recognition of the KAH3 strain. Three experiments 
consisting of quadruplicate wells for each sample condition were conducted (n = 12). Error bars 
represent standard error.   
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